A case description of pulmonary enteric adenocarcinoma with KRAS G12D mutation

被引：1
|
作者：
Fan, Fan [1 ]
Zhang, Haijun [1 ,2 ]
机构：
[1] Southeast Univ, Zhongda Hosp, Sch Med, Dept Oncol, Nanjing, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Sch Med, Dept Oncol, 87 Dingjiaqiao Rd, Nanjing, Peoples R China
来源：
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY | 2023年 / 13卷 / 12期
关键词：
CLASSIFICATION; TUMORS; LUNG;
D O I：
10.21037/qims-23-369
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：8787 / 8792
页数：6
相关论文
共 50 条
  • [21] Inhibition of KRAS G12D mutant with small molecules
    Lee, Dae-Hee
    Lee, Ji Yoon
    CANCER RESEARCH, 2024, 84 (06)
  • [22] A first-in-human phase I study of a novel KRAS G12D inhibitor HRS-4642 in patients with advanced solid tumors harboring KRAS G12D mutation
    Zhou, C.
    Li, W.
    Song, Z.
    Zhang, Y.
    Zhang, Y.
    Huang, D.
    Yang, Z.
    Zhou, M.
    Mao, R.
    Huang, C.
    Li, X.
    Wang, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1273 - S1273
  • [23] Selective epithelial activation of KRAS G12D mutation drives ductal pancreatic neoplasia in pigs
    Jara, Carlos P.
    Al-Gahmi, Al-Murtadha
    Le, Binh
    Carlson, Mark A.
    CANCER RESEARCH, 2024, 84 (02)
  • [24] Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma
    Bourdeaut, Franck
    Herault, Aurelie
    Gentien, David
    Pierron, Gaelle
    Ballet, Stelly
    Reynaud, Stephanie
    Paris, Regine
    Schleiermacher, Gudrun
    Baumann, Clarisse
    Philippe-Chomette, Pascale
    Gauthier-Villars, Marion
    Peuchmaur, Michel
    Radvanyi, Francois
    Delattre, Olivier
    JOURNAL OF MEDICAL GENETICS, 2010, 47 (12) : 859 - 862
  • [25] Association of KRAS G12D mutation with outcome in patients with pancreatic cancer after surgery.
    Mikayama, Yo
    Morinaga, Soichiro
    Watanabe, Takuo
    Numata, Masakatsu
    Tamagawa, Hiroshi
    Yamamoto, Naoto
    Shiozawa, Manabu
    Akaike, Makoto
    Yoichi, Kameda
    Matsukuma, Shoichi
    Miyagi, Yohei
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [26] Strategies to improve KRAS G12D inhibitor (MRTX1133) therapy in pancreatic ductal adenocarcinoma
    Gulay, Kevin Christian M.
    Esparza, Edgar
    Zhang, Xinlian
    Mose, Evangeline S.
    Weitz, Jonathan
    Pu, Minya
    Messer, Karen
    Lowy, Andrew M.
    Tiriac, Herve
    CANCER RESEARCH, 2022, 82 (22) : 50 - 50
  • [27] INCB161734: A novel, potent, and orally bioavailable KRAS G12D selective inhibitor demonstrates antitumor activity in KRAS G12D mutant tumors
    Farren, Matthew R.
    Roman, Valerie
    Gallion, Alexandra
    Allali-Hassani, Abdellah
    Sokolsky, Alexander
    Kong, Weixi
    Smith, Amanda
    Wang, Hui
    Correa, Gina
    Deller, Marc
    Epling, Leslie B.
    Procak, Jessica
    Zhang, Guofeng
    Pecko, Katherine
    Kennedy, Keith
    Boer, Jason
    Kurzeja-Lipinski, Kerri
    Covington, Maryanne
    Chen, Kwang-Jong
    Wallower, Renee
    Rocha, Jennifer
    Pan, Rina
    Perry, Anthony
    Yuska, Brad
    Wang, Xiaozhao
    Macarron, Ricardo
    Kim, Sunkyu
    CANCER RESEARCH, 2024, 84 (06)
  • [28] The clinical and genomic characteristics of KRAS G12D mutated cancers
    Lin, Guomin
    Yuan, Shaohua
    Pang, Fei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Targeting KRAS G12D/V mutations by KR12 in PDAC
    Matsuo, Nina
    Inoue, Takahiro
    Yoda, Hiroyuki
    Takatori, Atsushi
    Shinozaki, Yoshinao
    Watanabe, Takayoshi
    Koshikawa, Nobuko
    Jason, Lin
    Nagase, Hiroki
    CANCER SCIENCE, 2018, 109 : 518 - 518
  • [30] Oncogenic KRAS G12D mutation promotes dimerization through a second, phosphatidylserine-dependent interface: a model for KRAS oligomerization
    Lee, Ki-Young
    Enomoto, Masahiro
    Gebregiworgis, Teklab
    Gasmi-Seabrook, Genevieve M. C.
    Ikura, Mitsuhiko
    Marshall, Christopher B.
    CHEMICAL SCIENCE, 2021, 12 (38) : 12827 - 12837
12345